Optiscan Imaging (OIL) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Neutral

just now

Is Optiscan Imaging (ASX:OIL) Sharpening Its Governance Framework?

Highlights Optiscan Imaging Limited (ASX:OIL) has lodged its FY2026 Corporate Governance Statement and Appendix 4G with the ASX. The framework covers board responsibilities, director appointment checks and direct accountability of the company secretary. The disclosure provides greater governance transparency as Optiscan develops advanced optical imaging technology for healthcare applications. Optiscan Imaging Limited (ASX:OIL) has formalised its latest corporate governance disclosures, giving ...

Optiscan Imaging (OIL) News

Is Optiscan Imaging (ASX:OIL) Sharpening Its Governance Framework?

Appendix 4G & Corporate Governance Statement

2026 Annual Report

Preliminary Final Report

Companies Like Optiscan Imaging (ASX:OIL) Are In A Position To Invest In Growth - simplywall.st

Quarterly Activities/Appendix 4C Cash Flow Report

Roto-Gro International (ASX:OIL) Eases as Small-Cap Energy Stock Reflects Weaker Sector - Kalkine

Long Shortz with Optiscan Imaging: Breast cancer study begins

Long Shortz with Optiscan Imaging: Head and neck study accelerates

Optiscan to start new US breast cancer imaging study

Optiscan Signs New Research Agreement for Breast Study

Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule

Optiscan takes head and neck cancer imaging study to live surgical phase ahead of schedule

Health Check: No ‘burnt toast’ excuses as Optiscan trial runs ahead of schedule

Head and Neck Study Progressing Ahead of Schedule

Can Optiscan (ASX:OIL) Turn a First Launch Into Real Revenue?

Long Shortz with Optiscan: InSpecta launches in the US vet market

Optiscan launches InSpecta device in US veterinary market

Optiscan Imaging Launches First Clinical Device into US Veterinary Market

Optiscan Launches InSpecta Device for Veterinary Medicine

Biocurious: Silence is golden as Optiscan targets the US veterinarian market

Optiscan reaches halfway mark in breast cancer imaging study

Halfway Mark Reached in Optiscan Breast Cancer Study

Long Shortz with Optiscan Imaging: Advancing robotic surgery with Mayo Clinic

Optiscan marks Mayo Clinic milestone as robotic surgery collaboration progresses

Second Anniversary of Optiscan and Mayo Clinic Agreement

Non-Executive Director Ronnie Song Sold A Bunch Of Shares In Optiscan Imaging - simplywall.st

Change of Director's Interest Notice

Optiscan Receives $1.69m R&D Tax Refund

Quarterly Activities/Appendix 4C Cash Flow Report

Optiscan Submits InSpecta FDA Dossier

Change in substantial holding

Half Year Report - 31 December 2025

Appendix 4D

Quarterly Activities/Appendix 4C Cash Flow Report

Change of Director's Interest Notice x4

Notification regarding unquoted securities - OIL

Change of Director's Interest Notice

Investor Presentation

Optiscan Initiates Head & Neck Cancer Imaging Study

OIL Investor Webinar Invite

OIL Results of Annual General Meeting

OIL 2025 AGM Presentation

Optiscan Partners with ACL to Advance Digital Pathology

Quarterly Activities/Appendix 4C Cash Flow Report

Notice of Annual General Meeting/Proxy Form

Change of Director's Interest Notice x4

Optiscan ASX Small and Mid-Cap Conference Presentation

Issue of New Shares under the Rights Issue

Application for quotation of securities - OIL

Rights Issue Closure and Shortfall Notification

Letter to Ineligible Shareholders

Optiscan Despatches Entitlement Offer Documents

Appendix 4G & Corporate Governance Statement

2025 Annual Report

Appendix 4E - Preliminary Final Report

Entitlement Issue Prospectus

Proposed issue of securities - OIL

Optiscan Launches Entitlement Offer to Raise $17.75m

Quarterly Activities/Appendix 4C Cash Flow Report